Journal article icon

Journal article

Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial

Abstract:
Aims/hypothesis Previous studies have suggested that the haemoglobin glycation index (HGI) can be used as a predictor of diabetes-related complications in individuals with type 1 and type 2 diabetes. We investigated whether HGI was a predictor of adverse outcomes of intensive glucose lowering and of diabetes-related complications in general, using data from the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) tri... Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1007/s00125-017-4539-1

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Obstetrics & Gynaecology
Role:
Author
Expand authors...
Publisher:
Springer Berlin Heidelberg Publisher's website
Journal:
Diabetologia Journal website
Volume:
61
Issue:
4
Pages:
780–789
Publication date:
2018-01-08
Acceptance date:
2017-11-21
DOI:
EISSN:
0012-186X
ISSN:
1432-0428
Pubs id:
pubs:796087
URN:
uri:20c966d1-d797-4419-96c7-0b9314c6cf81
UUID:
uuid:20c966d1-d797-4419-96c7-0b9314c6cf81
Local pid:
pubs:796087

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP